Biomarker Technologies Market - Global Forecast to 2022
DUBLIN, May 16, 2018 /PRNewswire/ --
The "Biomarker Technologies Market by Profiling Technology (Chromatography, NGS, PCR, Mass Spectrometry, Immunoassay, Liquid Biopsy), Research Area (Proteomics, Lipidomics), Application (Biomarker Validation & Discovery) - Global Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.
The biomarker technologies market is expected to reach USD 74.51 Billion by 2022 from USD 46.97 Billion in 2017, at a CAGR of 9.7% during the forecast period.
While significant advances have been made in the area of biomarkers, translating them into useful clinical assays is tedious and a prime hurdle to the clinical use of these biomarkers. The growth of this market is driven by factors such as increasing healthcare expenditure, increase in R&D funding, and the increasing utility of biomarkers for diagnostic purposes, and rising biomarker research.
Based on product type, the biomarker technologies market is classified into consumables, instruments, services, and software/informatics. In 2017, the consumables segment was expected to account for the largest share of the market due to their larger sales volume as compared to instruments. The consumables market is further segmented into reagents & kits and chromatography columns. In 2017, the reagents & kits segment accounted for the largest share of the consumables market.
By profiling technology, the biomarker technologies market is classified into immunoassay, PCR, imaging technology, mass spectrometry, NGS, chromatography, cytogenetics, and other technologies. The immunoassay segment accounted for the largest share in 2017. This segment is further divided into ELISA, western blot, and protein microarray.
In 2017, the ELISA segment accounted for the largest share of the immunoassay market. ELISA can simultaneously quantify levels of multiple proteins and have the potential to accelerate the validation of protein biomarkers for clinical use. Such factors are increasing the use of ELISA for confirmatory studies in biomarker discovery.
In 2017, North America accounted for the largest share of the biomarker technologies market. Asia Pacific is expected to register the highest growth from 2017 to 2022 for the biomarker technologies market. Factors such as the rising incidence of cancer, growing geriatric population, and support from private and public organizations for biomarker research are driving the growth of this regional segment.
Key Topics Covered:
1 Biomarker Technologies Market: Introduction
2 Biomarker Technologies Market: Research Methodology
3 Biomarker Technologies Market, By Test Type
3.1 Introduction
3.2 Solid Biopsy
3.3 Liquid Biopsy
4 Biomarkers Liquid Biopsy Market, By Application
4.1 Introduction
4.2 Clinical Diagnostics
4.3 Research
4.4 Drug Discovery and Development
5 Liquid Biopsy Market, By Technology
5.1 DDPCR
5.2 NGS
5.3 Mass Spectrometry
5.4 DHPLC
5.5 Other
6 Biomarker Technologies Market, By Product
6.1 Consumables
6.2 Instruments
6.3 Services
6.4 Software/Informatics
7 Biomarker Product Market, By Application
7.1 Consumables
7.1.1 Diagnostics
7.1.1.1 Clinical Use
7.1.1.2 Research
7.1.2 Drug Discovery & Development
7.2 Instruments
7.2.1 Diagnostics
7.2.1.1 Clinical Use
7.2.1.2 Research
7.2.2 Drug Discovery & Development
7.3 Services
7.3.1 Diagnostics
7.3.1.1 Clinical Use
7.3.1.2 Research
7.3.2 Drug Discovery & Development
7.4 Software/Informatics
7.4.1 Diagnostics
7.4.1.1 Clinical Use
7.4.1.2 Research
7.4.2 Drug Discovery & Development
8 Biomarker Technologies Market, By Profiling Technology
8.1 Immunoassay
8.1.1 Elisa
8.1.2 Western Blot
8.1.3 Protein Microarray
8.2 PCR
8.3 Mass Spectrometry
8.4 NGS
8.5 Chromatography
8.6 Imaging Technologies
8.7 Cytogenetics
8.8 Others
9 Biomarker Profiling Technology Market, By Application
9.1 Immunoassay
9.2 PCR
9.3 Mass Spectrometry
9.4 NGS
9.5 Imaging Technologies
9.6 Cytogenetics
9.7 Others
10 Biomarker Disease Indication Market, By Application
10.1 Cancer
10.1.1 Diagnostics
10.1.2 Drug Discovery & Development
10.2 Infectious Diseases
10.2.1 Diagnostics
10.2.2 Drug Discovery & Development
10.3 Autoimmune Disorders
10.3.1 Diagnostics
10.3.2 Drug Discovery & Development
10.4 Neurological Disorders
10.4.1 Diagnostics
10.4.2 Drug Discovery & Development
10.5 Cardiovascular Disorders
10.5.1 Diagnostics
10.5.2 Drug Discovery & Development
10.6 Other
10.6.1 Diagnostics
10.6.2 Drug Discovery & Development
11 Biomarker Technologies Market, By Application
11.1 Biomarker Identification, Validation & Development Research
11.2 Routine Biomarker-Based Tests
12 Biomarker Technology Applications Market, By Product
12.1 Biomarker Identification, Validation & Development Research
12.1.1 Consumables
12.1.2 Instruments
12.1.3 Services
12.1.4 Software
12.2 Routine Biomarker-Based Tests
12.2.1 Consumables
12.2.2 Instruments
12.2.3 Services
12.2.4 Software
13 Biomarker Technologies Market, By Research Area
13.1 Genomics
13.2 Proteomics
13.3 Metabolomics
13.3.1 Metabolic Flux
13.3.2 Lipidomics
13.3.3 Others
13.4 Other Research Types
14 Market Share Analysis
14.1 Biomarker Technologies Market for Mass Spectrometry: Market Share Analysis
14.2 Biomarker Technologies Market for Chromatography: Market Share Analysis
15 Biomarker Technologies Market, By Region
Companies Mentioned
- Agilent Technologies (US)
- Thermo Fisher Scientific (US)
- Roche (Switzerland)
- Waters Corporation (US)
- Danaher Corporation (US)
- Shimadzu Corporation (Japan)
- Bio-Rad Laboratories (US)
For more information about this report visit https://www.researchandmarkets.com/research/tx3xs4/biomarker?w=5
Media Contact:
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article